liver fibrosis
Preventive effect of halofuginone on concanavalin A-induced liver fibrosis.
8
Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children
7
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
14
Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.
14
The chemokine CCL3 promotes experimental liver fibrosis in mice.
10
Noninvasive Means of Diagnosing Liver Fibrosis in Hepatitis C
5
Modulation of extracellular matrix proteins and hepatate stellate cell activation following gadolinium chloride induced Kuffer cell blockade in an experimental model of liver fibrosis/cirrhosis
10
Activation of protein serine/threonine phosphatase PP2Cα efficiently prevents liver fibrosis.
13
Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
10
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
7
Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels
4
No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
7
The effect of erythropoietin on platelet distribution width during ischemia reperfusion injury in rats
6
Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease
7
Rev. Soc. Bras. Med. Trop. vol.44 número3
1
Expression and distribution of connexin 32 in rat liver with experimentally induced fibrosis
5
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
19
Performance of real-time elastography for the staging of hepatic fibrosis: a meta-analysis.
15
Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.
8
Rev. Assoc. Med. Bras. vol.60 número1
6